According to SURMOUNT-4 trial data (2024), patients on Zepbound (Tirzepatide 15mg) maintained an average 21% body weight loss over 88 weekssignificantly higher than Semaglutide (Wegovy)s 15% in similar trials
+ Common side effects may include nausea, constipation, diarrhea, or mild stomach discomfort, especially during the early stages of treatment
Patients in San Antonio and across the country can connect with Prime Vitality Cares physician-led team for a comprehensive evaluation at primevitalitycare.com/telehealth or by calling (210) 876-1635 or via Email: [email protected]
No data transparency If you cant see whos progressing, whos escalating doses, or whos ready to stop you cant manage the benefit effectively
doi: 10.1097/mcg.0000000000001485
Is GHK-Cu injection legal